Faruqi & Faruqi Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV
13 sept. 2024 09h42 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Verve To Contact Him Directly To Discuss Their Options If...
Faruqi & Faruqi Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE
13 sept. 2024 09h40 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Sage To Contact Him Directly To Discuss Their Options If...
Faruqi & Faruqi Reminds Vicor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2024 - VICR
13 sept. 2024 09h39 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Vicor To Contact Him Directly To Discuss Their Options If...
Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCR
13 sept. 2024 09h37 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lifecore To Contact Him Directly To Discuss Their Options If...
Faruqi & Faruqi Reminds Extreme Networks Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 - EXTR
13 sept. 2024 09h36 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Extreme Networks To Contact Him Directly To Discuss Their...
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
13 sept. 2024 08h30 HE
|
PRISM MarketView
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
34/2024・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
13 sept. 2024 06h16 HE
|
Trifork Group AG
Company announcement no. 34 / 2024 Schindellegi, Switzerland – 13 September 2024 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated...
BIO-key International Enters into $1.9 Million Warrant Inducement
12 sept. 2024 13h18 HE
|
BIO-key International, Inc.
BIO-key International (Nasdaq: BKYI) Enters into $1.9 Million Warrant Inducement
AmpliTech Group’s AGTGSS Division Receives Initial Order For Its Midband 5G Radio Networks From Historic University of Edinburgh UK
12 sept. 2024 08h30 HE
|
AmpliTech Group, Inc.
AmpliTech Group’s AGTGSS Division Receives Initial Order For Its Midband 5G Radio Networks From Historic University of Edinburgh, UK
Xeriant NEXBOARD™ Update: Finalizing Testing and Setting Up Production
12 sept. 2024 08h05 HE
|
Xeriant, Inc.
Xeriant (OTCQB: XERI) preparing NEXBOARD™ for certification testing and initial commercial production.